Showing results (41-50 of 370) with videos related to
Sort By:
Pageof 37
Cancer Research|June 1, 1984
4-aminoazobenzene and N,N-dimethyl-4-aminoazobenzene as equipotent hepatic carcinogens in male C57BL/6 X C3H/He F1 mice and characterization of N-(Deoxyguanosin-8-yl)-4-aminoazobenzene as the major persistent hepatic DNA-bound dye in these miceK B Delclos, W G Tarpley, E C Miller, et al.Carcinogenesis|January 1, 1982
Labeled 1,N6-ethenoadenosine and 3,N4-ethenocytidine in hepatic RNA of mice given[ethyl-1,2(-3)H or ethyl-1(-14)C]ethyl carbamate (urethan)M L Ribovich, J A Miller, E C Miller, et al.Cancer Research|July 1, 1985
Further characterization of the DNA adducts formed by electrophilic esters of the hepatocarcinogens 1'-hydroxysafrole and 1'-hydroxyestragole in vitro and in mouse liver in vivo, including new adducts at C-8 and N-7 of guanine residuesR W Wiseman, T R Fennell, J A Miller, et al.Biochemical and Biophysical Research Communications|April 29, 1987
Hepatic DNA and RNA adduct formation from the carcinogen 7-hydroxymethyl-12-methylbenz[a]anthracene and its electrophilic sulfuric acid ester metabolite in preweanling rats and miceY J Surh, C C Lai, J A Miller, et al.Carcinogenesis|January 1, 1981
Comparative carcinogenicities and reactivities of N-myristoyloxy-N-acetyl-2-aminofluorene and its 7-iodo derivativeR P Fuchs, M C Lang, E C Miller, et al.Journal of Supramolecular Structure and Cellular Biochemistry|January 1, 1981
The in vivo formation and repair of DNA adducts from 1'-hydroxysafroleD H Phillips, P C Hanawalt, J A Miller, et al.Journal of the National Cancer Institute|December 1, 1976
Hepatocarcinogenicity of estragole (1-allyl-4-methoxybenzene) and 1'-hydroxyestragole in the mouse and mutagenicity of 1'-acetoxyestragole in bacteriaN R Drinkwater, E C Miller, J A Miller, et al.Cancer Research|November 1, 1985
Major role of hepatic sulfotransferase activity in the metabolic activation, DNA adduct formation, and carcinogenicity of 1'-hydroxy-2',3'-dehydroestragole in infant male C57BL/6J x C3H/HeJ F1 miceT R Fennell, R W Wiseman, J A Miller, et al.Cancer Research|January 1, 1977
Aflatoxin B1-2,3-oxide as a probable intermediate in the covalent binding of aflatoxins B1 and B2 to rat liver DNA and ribosomal RNA in vivoD H Swenson, J K Lin, E C Miller, et al.Cancer Research|August 1, 1978
Reduced nicotinamide adenine dinucleotide phosphate-dependent formation of 2,3-dihydro-2,3-dihydroxyaflatoxin B1 from aflatoxin B1 by hepatic microsomesJ K Lin, K A Kennan, E C Miller, et al.Pageof 37